Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial

医学 帕雷昔布 羟考酮 随机对照试验 优势比 置信区间 塞来昔布 止痛药 肝细胞癌 不利影响 麻醉 外科 内科学 类阿片 受体
作者
Ning Lyu,Yanan Kong,Xiaoxian Li,Na Guo,Jinfa Lai,Jibin Li,Ming Zhao
出处
期刊:Journal of The American College of Radiology [Elsevier BV]
卷期号:19 (1): 61-70 被引量:8
标识
DOI:10.1016/j.jacr.2021.09.029
摘要

Pain is one of the most common side effects of transarterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma. The goal of this study is to compare the analgesic effect among celecoxib, parecoxib, and oxycodone in patients undergoing TACE.This prospective study was a randomized, paralleled trial in which 213 patients were enrolled. Patients were assigned at the ratio of 1:1:1 to receive celecoxib, parecoxib, or controlled-release oxycodone 1 hour before TACE (T0) and once every 12 hours for 2 days after TACE. Pain scores, pain intensity, and adverse events in each time interval were evaluated and compared among the 3 groups.The mean pain score 12 hours after T0 in the parecoxib group (2.8) was lower than that in the celecoxib (4.4; P = .001) and oxycodone groups (4.2; P = .005). The number of patients suffering severe pain was 10 (14.7%) in the parecoxib, 25 (36.8%) in the celecoxib, and 23 (32.9%) in the oxycodone groups (P = .009). Twelve hours after T0, the incidence of grade 3 vomiting in the parecoxib group (2.9%) was significantly lower than that in the oxycodone group (17.1%; P = .006). In the multivariate analysis, nonparecoxib prophylactic analgesia (odds ratio [OR], 4.620; 95% confidence interval [CI], 1.877-11.370; P = .001) as well as embolization of the gallbladder (OR, 8.666; 95% CI, 2.402-31.262; P = .001) and normal liver parenchyma (OR, 3.278; 95% CI, 1.409-7.627; P = .006) were the independent factors of severe pain intensity 12 hours after T0.Parecoxib is superior to oxycodone and celecoxib for pain control with fewer adverse events. Therefore, we recommend parecoxib as a priority strategy for TACE-related pain control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xyz发布了新的文献求助10
刚刚
牛小牛发布了新的文献求助10
刚刚
林子青发布了新的文献求助10
1秒前
wuxidixi发布了新的文献求助10
1秒前
demonox发布了新的文献求助10
2秒前
LL发布了新的文献求助10
2秒前
梁言发布了新的文献求助10
2秒前
zzz发布了新的文献求助10
3秒前
早岁发布了新的文献求助10
3秒前
4秒前
白羊完成签到,获得积分10
4秒前
hjh完成签到,获得积分10
4秒前
iNk应助漂亮芸采纳,获得20
4秒前
香蕉觅云应助Gilana采纳,获得10
4秒前
orixero应助黑黑黑采纳,获得10
4秒前
ht发布了新的文献求助10
5秒前
李健的小迷弟应助123456采纳,获得10
5秒前
ding应助xyz采纳,获得10
5秒前
6秒前
Colossus完成签到,获得积分10
6秒前
科研眼镜蛇关注了科研通微信公众号
6秒前
6秒前
7秒前
wyr发布了新的文献求助10
7秒前
7秒前
12完成签到,获得积分10
7秒前
7秒前
8秒前
小巧的虔应助科研废物采纳,获得10
8秒前
婷婷子完成签到,获得积分10
8秒前
Cheng_Wei完成签到,获得积分10
8秒前
8秒前
Livy发布了新的文献求助10
8秒前
8秒前
深情安青应助月亮褪色了采纳,获得10
8秒前
9秒前
9秒前
whisper发布了新的文献求助10
10秒前
可爱的函函应助kelly采纳,获得10
10秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974779
求助须知:如何正确求助?哪些是违规求助? 3519193
关于积分的说明 11197417
捐赠科研通 3255311
什么是DOI,文献DOI怎么找? 1797760
邀请新用户注册赠送积分活动 877150
科研通“疑难数据库(出版商)”最低求助积分说明 806187